Home
>
National Drug Code (NDC)
>
Nadolol
Nadolol - 51079-812-20 - (nadolol)
Drug Information of Nadolol
| Product NDC: | 51079-812 |
| Proprietary Name: | Nadolol |
| Non Proprietary Name: | nadolol |
| Active Ingredient(s): | 20 mg/1 & nbsp; nadolol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nadolol
| Product NDC: | 51079-812 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074172 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110114 |
Package Information of Nadolol
| Package NDC: | 51079-812-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-812-20) > 1 TABLET in 1 BLISTER PACK (51079-812-01) |
NDC Information of Nadolol
| NDC Code | 51079-812-20 |
| Proprietary Name | Nadolol |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-812-20) > 1 TABLET in 1 BLISTER PACK (51079-812-01) |
| Product NDC | 51079-812 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nadolol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110114 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | NADOLOL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
